Gregg, Nicholas M. http://orcid.org/0000-0002-6151-043X
Sladky, Vladimir
Nejedly, Petr
Mivalt, Filip http://orcid.org/0000-0002-0693-9495
Kim, Inyong
Balzekas, Irena http://orcid.org/0000-0003-2731-9188
Sturges, Beverly K.
Crowe, Chelsea
Patterson, Edward E.
Van Gompel, Jamie J. http://orcid.org/0000-0001-8087-7870
Lundstrom, Brian N. http://orcid.org/0000-0002-5310-5549
Leyde, Kent
Denison, Timothy J. http://orcid.org/0000-0002-5404-4004
Brinkmann, Benjamin H. http://orcid.org/0000-0002-2392-8608
Kremen, Vaclav http://orcid.org/0000-0001-9844-7617
Worrell, Gregory A. http://orcid.org/0000-0003-2916-0553
Funding for this research was provided by:
American Epilepsy Society (Research & Training Fellowship for Clinicians)
National Institutes of Health (UH2&3-NS95495)
National Institutes of Health,United States (U01-NS073557, R01-NS92882, U01-NS073557)
Epilepsy Foundation (Epilepsy Innovation Institute, My Seizure Gauge)
Article History
Received: 12 October 2021
Accepted: 3 December 2021
First Online: 20 December 2021
Competing interests
: G.A.W., B.N.L., J.J.V.V., and B.H.B. declare intellectual property licensed to Cadence Neuroscience. N.M.G., G.A.W., and B.N.L. are investigators for the Medtronic Deep Brain Stimulation Therapy for Epilepsy Post-Approval Study. B.N.L is an investigator for the NeuroPace RNS System Responsive Stimulation for Adolescents with Epilepsy (RESPONSE) study and Neuroelectrics tDCS for Patients with Epilepsy Study. V.K. consults for CertiCon. K.L is the founder of Cadence Neuroscience. T.J.D. is a shareholder in Bioinduction Ltd, and co-founder and shareholder of Amber Therapeutics Ltd., consults for Synchron and Cortec Neuro, and has consulted for Inspire, InBrain and Medtronic. I.B. has received compensation from an internship with Cadence Neuroscience Inc. The remaining authors declare that they have no competing interests. The Medtronic Summit RC + S devices used in this research were provided free of charge as part of NIH Brain Initiative UH2/UH3-NS95495.